Skip to main content

What’s New

Latest News

News
11/11/2024
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score...
11/11/2024
Advances in Inflammatory Bowel Disease Network
Advances in Inflammatory Bowel Disease Network
News
11/06/2024
Multiple lots of cinacalcet tablets from Accord Healthcare Inc. and Dr Reddy’s Laboratories have been recalled due to the presence of an N-nitroso cinacalcet impurity above the acceptable daily intake limit, with potential health consequences...
Multiple lots of cinacalcet tablets from Accord Healthcare Inc. and Dr Reddy’s Laboratories have been recalled due to the presence of an N-nitroso cinacalcet impurity above the acceptable daily intake limit, with potential health consequences...
Multiple lots of cinacalcet...
11/06/2024
Pharmacy Learning Network
Pharmacy Learning Network
News
11/06/2024
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of...
11/06/2024
First Report Managed Care
First Report Managed Care
News
11/06/2024
According to a study published in Nature, endometrial cancer (EC) cases are on the rise, and 10% to 20% of patients with EC experience distant recurrence. In this study, in researchers aimed to predict distant recurrence of EC to improve...
According to a study published in Nature, endometrial cancer (EC) cases are on the rise, and 10% to 20% of patients with EC experience distant recurrence. In this study, in researchers aimed to predict distant recurrence of EC to improve...
According to a study published...
11/06/2024
Journal of Clinical Pathways
Journal of Clinical Pathways
Late-Breaking Trials
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Vascular Disease Management
News
11/06/2024
According to results from a phase 3 trial, the addition of concurrent thoracic radiotherapy to first-line icotinib improved survival among patients with EGFR-mutated oligo-organ metastatic non-small cell lung cancer.
According to results from a phase 3 trial, the addition of concurrent thoracic radiotherapy to first-line icotinib improved survival among patients with EGFR-mutated oligo-organ metastatic non-small cell lung cancer.
According to results from a...
11/06/2024
Oncology
Oncology
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
Psych Congress Network

Latest Research

Volume 32 - Issue 6 - September 2024
Vol. 32, Issue 6, Issue November 2024
Vol. 32, Issue 5, Issue November 2024

HMP Global Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Featured Interviews

Dr Craig Chepke
Exclusive Interview
05/21/2024
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
Dr Craig Chepke discusses his...
05/21/2024
Psych Congress Network
Nurses Hoberg and Kempf
Videos
03/21/2024

Featuring Amber Hoberg, PMHNP-BC, and Brooke Kempf, PMHNP-BC

Featuring Amber Hoberg, PMHNP-BC, and...
Nurses Hoberg and Kempf discuss how clinicians and caregivers alike can maintain composure and patience when treating patients with dementia.
Nurses Hoberg and Kempf discuss how clinicians and caregivers alike can maintain composure and patience when treating patients with dementia.
Nurses Hoberg and Kempf discuss...
03/21/2024
Psych Congress Network
Bradley Corr, MD
Conference Coverage
03/21/2024

Featuring Bradley Corr, MD

Featuring Bradley Corr, MD
At the 2024 SGO Annual Meeting on Women’s Cancers, Bradley Corr, MD, discusses the results from a study evaluating rucaparib maintenance therapy for patients with metastatic or recurrent endometrial cancer.
At the 2024 SGO Annual Meeting on Women’s Cancers, Bradley Corr, MD, discusses the results from a study evaluating rucaparib maintenance therapy for patients with metastatic or recurrent endometrial cancer.
At the 2024 SGO Annual Meeting...
03/21/2024
Oncology
Constantino Peña, MD, Miami Cancer Institute
Videos
03/21/2024

Featuring Constantino Peña, MD

Featuring Constantino Peña, MD ...
Constantino Peña, MD, discusses the importance of a multidisciplinary approach within the field of interventional oncology.
Constantino Peña, MD, discusses the importance of a multidisciplinary approach within the field of interventional oncology.
Constantino Peña, MD, discusses...
03/21/2024
IO Learning
Jing-Zhou Hou, MD, PhD
Videos
03/21/2024

Featuring Jing-Zhou Hou, MD, PhD

Featuring Jing-Zhou Hou, MD, PhD ...
Jing-Zhou Hou, MD, PhD, discusses how the standard of care for CLL has evolved among community oncologists since 2020 and how clinical and demographic factors impact treatment selection.
Jing-Zhou Hou, MD, PhD, discusses how the standard of care for CLL has evolved among community oncologists since 2020 and how clinical and demographic factors impact treatment selection.
Jing-Zhou Hou, MD, PhD,...
03/21/2024
Journal of Clinical Pathways
Jack Jennings, MD, PhD, Washington University in St Louis
Videos
02/06/2024
At the 2024 SIO Annual Meeting, Jack Jennings, MD, PhD, discussed the role of the interventional oncologist when treating primary or metastatic sarcomas of the bone or soft tissue.
At the 2024 SIO Annual Meeting, Jack Jennings, MD, PhD, discussed the role of the interventional oncologist when treating primary or metastatic sarcomas of the bone or soft tissue.
At the 2024 SIO Annual Meeting,...
02/06/2024
IO Learning
Saby George, MD
Conference Coverage
01/27/2024
Saby George shares insights from the CheckMate 67T evaluating the subcutaneous administration of nivolumab for patients with clear cell renal cell carcinoma, compared with the intravenous administration.
Saby George shares insights from the CheckMate 67T evaluating the subcutaneous administration of nivolumab for patients with clear cell renal cell carcinoma, compared with the intravenous administration.
Saby George shares insights from...
01/27/2024
Oncology
Michiel van der Heijden, MD 
Conference Coverage
01/26/2024
Michiel van der Heijden, MD, discusses the subgroup analyses of the phase 3 EV-302 study, evaluating enfortumab vedotin plus pembrolizumab among patients with locally advanced or metastatic urothelial carcinoma in the first-line setting.
Michiel van der Heijden, MD, discusses the subgroup analyses of the phase 3 EV-302 study, evaluating enfortumab vedotin plus pembrolizumab among patients with locally advanced or metastatic urothelial carcinoma in the first-line setting.
Michiel van der Heijden, MD,...
01/26/2024
Oncology
Thierry André, MD, Saint Antoine Hospital
Videos
01/23/2024
Thierry Andre, MD, discusses the first results from the CheckMate 8HW study exploring nivolumab plus chemotherapy for the first-line treatment of microsatellite instability-high, mismatch repair-deficient metastatic colorectal cancer.
Thierry Andre, MD, discusses the first results from the CheckMate 8HW study exploring nivolumab plus chemotherapy for the first-line treatment of microsatellite instability-high, mismatch repair-deficient metastatic colorectal cancer.
Thierry Andre, MD, discusses the...
01/23/2024
Oncology
Riccardo Lencioni, MD, University of Pisa School of Medicine
Videos
01/23/2024
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares...
01/23/2024
Oncology

Advertisement

Advertisement